Перейти к информации о продукте
1 из 1

Aproxi (Aprepitant)

Aproxi (Aprepitant)

Просмотреть всю информацию
Packaging Size: 3 capsules/pack
Strength: 125 mg / 80 mg
Composition: Aprepitant
Treatment: Prevention of chemotherapy-induced nausea and vomiting (CINV), including acute and delayed vomiting associated with cancer chemotherapy.
Form: Capsule
Brand: Aproxi
Quantity Unit: Capsule/Box

Aproxi (Aprepitant) is an oral prescription antiemetic medicine used primarily to prevent chemotherapy-induced nausea and vomiting (CINV). It is a selective NK1 receptor antagonist that blocks substance P signaling in the brain, helping prevent both acute and delayed nausea and vomiting associated with cancer chemotherapy. Aproxi is often used in combination with other antiemetic medicines such as a 5-HT3 antagonist and dexamethasone.

Everyone Deserves Access to Life-saving Treatment Of Cancer. We are a Trusted Cancer Medicine seller delivering certified medications to every corner of the world.